209 related articles for article (PubMed ID: 20188013)
1. Anosognosia in Alzheimer's disease: the role of impairment levels in assessment of insight across domains.
Leicht H; Berwig M; Gertz HJ
J Int Neuropsychol Soc; 2010 May; 16(3):463-73. PubMed ID: 20188013
[TBL] [Abstract][Full Text] [Related]
2. [Methods for assessing impaired insight in Alzheimer's disease--a critical review].
Leicht H; Gertz HJ
Psychiatr Prax; 2009 Mar; 36(2):58-66. PubMed ID: 18726844
[TBL] [Abstract][Full Text] [Related]
3. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
[TBL] [Abstract][Full Text] [Related]
4. Retrieval monitoring and anosognosia in Alzheimer's disease.
Gallo DA; Chen JM; Wiseman AL; Schacter DL; Budson AE
Neuropsychology; 2007 Sep; 21(5):559-68. PubMed ID: 17784804
[TBL] [Abstract][Full Text] [Related]
5. Anosognosia and Alzheimer's disease: the role of depressive symptoms in mediating impaired insight.
Smith CA; Henderson VW; McCleary CA; Murdock GA; Buckwalter JG
J Clin Exp Neuropsychol; 2000 Aug; 22(4):437-44. PubMed ID: 10923053
[TBL] [Abstract][Full Text] [Related]
6. Anosognosia in very mild Alzheimer's disease but not in mild cognitive impairment.
Kalbe E; Salmon E; Perani D; Holthoff V; Sorbi S; Elsner A; Weisenbach S; Brand M; Lenz O; Kessler J; Luedecke S; Ortelli P; Herholz K
Dement Geriatr Cogn Disord; 2005; 19(5-6):349-56. PubMed ID: 15802909
[TBL] [Abstract][Full Text] [Related]
7. Two dimensions of anosognosia in patients with Alzheimer's disease: reliability and validity of the Japanese version of the Anosognosia Questionnaire for Dementia (AQ-D).
Sato J; Nakaaki S; Murata Y; Shinagawa Y; Matsui T; Hongo J; Tatsumi H; Akechi T; Furukawa TA
Psychiatry Clin Neurosci; 2007 Dec; 61(6):672-7. PubMed ID: 18081630
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal assessment of deficit unawareness in Alzheimer's disease.
Vasterling JJ; Seltzer B; Watrous WE
Neuropsychiatry Neuropsychol Behav Neurol; 1997 Jul; 10(3):197-202. PubMed ID: 9297713
[TBL] [Abstract][Full Text] [Related]
9. [Unawareness of deficits in Alzheimer's disease: a multidimentional approach].
Trouillet R; Gély-Nargeot MC; Derouesné C
Psychol Neuropsychiatr Vieil; 2003 Jun; 1(2):99-110. PubMed ID: 15683946
[TBL] [Abstract][Full Text] [Related]
10. Clinical associations of anosognosia in mild cognitive impairment and Alzheimer's disease.
Mak E; Chin R; Ng LT; Yeo D; Hameed S
Int J Geriatr Psychiatry; 2015 Dec; 30(12):1207-14. PubMed ID: 25754519
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence of anosognosia in Alzheimer's disease].
Turró-Garriga O; Conde-Sala JL; Reñé-Ramírez R; López-Pousa S; Gascón-Bayarri J; Garre-Olmo J
Med Clin (Barc); 2014 Jul; 143(1):13-9. PubMed ID: 23830548
[TBL] [Abstract][Full Text] [Related]
12. Mnemonic anosognosia in Alzheimer's disease: a test of Agnew and Morris (1998).
Ansell EL; Bucks RS
Neuropsychologia; 2006; 44(7):1095-102. PubMed ID: 16324727
[TBL] [Abstract][Full Text] [Related]
13. [Awareness of deficits and anosognosia in Alzheimer's disease].
Antoine C; Antoine P; Guermonprez P; Frigard B
Encephale; 2004; 30(6):570-7. PubMed ID: 15738860
[TBL] [Abstract][Full Text] [Related]
14. Anosognosia and procedural learning in Alzheimer's disease.
Starkstein SE; Sabe L; Cuerva AG; Kuzis G; Leiguarda R
Neuropsychiatry Neuropsychol Behav Neurol; 1997 Apr; 10(2):96-101. PubMed ID: 9150509
[TBL] [Abstract][Full Text] [Related]
15. Anosognosia and depression in patients with Alzheimer's dementia.
Verhülsdonk S; Quack R; Höft B; Lange-Asschenfeldt C; Supprian T
Arch Gerontol Geriatr; 2013; 57(3):282-7. PubMed ID: 23597486
[TBL] [Abstract][Full Text] [Related]
16. Cognitive complaint in mild cognitive impairment and Alzheimer's disease.
Clément F; Belleville S; Gauthier S
J Int Neuropsychol Soc; 2008 Mar; 14(2):222-32. PubMed ID: 18282320
[TBL] [Abstract][Full Text] [Related]
17. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
18. Cognitive reserve and anosognosia in questionable and mild dementia.
Spitznagel MB; Tremont G
Arch Clin Neuropsychol; 2005 Jun; 20(4):505-15. PubMed ID: 15896563
[TBL] [Abstract][Full Text] [Related]
19. Severity of dementia, anosognosia, and depression in relation to the quality of life of patients with Alzheimer disease: discrepancies between patients and caregivers.
Conde-Sala JL; Reñé-Ramírez R; Turró-Garriga O; Gascón-Bayarri J; Campdelacreu-Fumadó J; Juncadella-Puig M; Rico-Pons I; Garre-Olmo J
Am J Geriatr Psychiatry; 2014 Feb; 22(2):138-47. PubMed ID: 23567444
[TBL] [Abstract][Full Text] [Related]
20. Assessing quality of life in Taiwanese patients with Alzheimer's disease.
Fuh JL; Wang SJ
Int J Geriatr Psychiatry; 2006 Feb; 21(2):103-7. PubMed ID: 16416471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]